A Novel Mutation at HBA1: c.349G>T Causing α-Thalassemia in a Chinese Family

Zhenzhen Yin,Yuqi Hao,Xiaoyan Huang,Xiaohang Chen,Shiping Chen,Gaochi Li,Chuyan Chen,Fengxiang Wei
DOI: https://doi.org/10.1080/03630269.2021.1925292
Hemoglobin
Abstract:α-Thalassemia (α-thal) is one of the most common genetic diseases in Southern China. Although more than 300 α-thal mutations have been reported in the world, the mutation spectrum is still not comprehensive. In this study, a novel mutation (HBA1: c.349G>T) in a newborn (proband) was first found by next-generation sequencing (NGS). Subsequently, hematological analysis and thalassemia genetic testing were performed for the family members. The results showed that both the proband and her mother were heterozygotes for this novel mutation and presented abnormal hematological indices. Based on the features observed in clinical practice, this novel mutation was considered as a type of α-thal variation.
What problem does this paper attempt to address?